by
Super Admin
-
18 hours ago
NASHVILLE, Tenn., Sept. 17, 2025 /PRNewswire/ -- The wait is almost over. Four-time GRAMMY® Award-winning Curb Records duo for KING + COUNTRY announce the arrival of their brand-new single, "World on Fire feat. Taylor Hill," releasing everywhere on O...
by
Super Admin
-
18 hours ago
Recognized for Completeness of Vision and Ability to Execute NEW YORK, Sept. 17, 2025 /PRNewswire/ -- Qodo, the Agentic Code Quality platform, today announced that Qodo has been positioned by Gartner as a Visionary in the Magic Quadrant for AI Code A...
by
Super Admin
-
18 hours ago
Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck Cancers Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck Cancers
by
Super Admin
-
18 hours ago
Castle Biosciences has been included in the inaugural 2025 America’s Greatest Companies list, published by Newsweek.
by
Super Admin
-
18 hours ago
Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profile
by
Super Admin
-
18 hours ago
Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)
by
Super Admin
-
18 hours ago
BASEL, Switzerland and LONDON and NEW YORK and DURHAM, N.C., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Priovant Therapeutics today announced positive results from the Phase 3 VALOR study evaluating brepocitinib in der...
by
Super Admin
-
18 hours ago
Highlights discovery of novel targets in T cell-driven autoimmune disorders; initial findings to be presented at the ACR Convergence 2025 Highlights discovery of novel targets in T cell-driven autoimmune disorders; initial findings to be presented at...
by
Super Admin
-
18 hours ago
Organizational restructuring including a 50% reduction in workforce that is anticipated to result in annualized cost savings of approximately $13M
by
Super Admin
-
18 hours ago
Six poster presentations showcase clinical and real-world data in major depressive disorder, Alzheimer’s disease agitation, narcolepsy, and obstructive sleep apnea Six poster presentations showcase clinical and real-world data in major depressive dis...
by
Super Admin
-
18 hours ago
VANCOUVER, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce it has received approval to list its common shares (the “Shares”) on...
by
Super Admin
-
18 hours ago
TORONTO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI | OTCQB: CPIFF) ("Carlton Precious" or the "Company") announces that the Company has filed a notice of intention to distribute securities (Form 45-102F1) (the “Notice”) i...
by
Super Admin
-
18 hours ago
Pilavapadin 10 mg resulted in a two-point reduction from baseline in average daily pain scores (ADPS) by week 11 and was well tolerated in PROGRESS Phase 2b study Pilavapadin 10 mg resulted in a two-point reduction from baseline in average daily pain...
by
Super Admin
-
18 hours ago
The study, published in The European Journal of Ophthalmology, included 29 publications and concluded that favorable long-term safety and efficacy profiles make OMNI a beneficial treatment option for patients with primary open-angle glaucoma The stud...